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Daptomycin (DPT) was the first lipopeptide antibiotic available for commercialization. It is active 
against gram-positive bacteria, including resistant strains. This work aimed to develop and validate a 
turbidimetric microbiologic assay to determine daptomycin in an injectable form. A 3x3 design was 
employed, at concentrations of 1, 2 and 4.0 µg/mL. The microorganism test used was Staphylococcus 
aureus ATCC 6538p, and Antibiotic Medium 3 was used as the culture medium. Method validation 
demonstrated that the bioassay was linear (r=0.9995), precise (RSD=2.58%), accurate (recovery 100.48± 
2.11%), and robust. Degradation kinetics was also performed in an alkaline medium, indicating that 
daptomycin degradation follows first order kinetics under these conditions. The analyses of degraded 
solutions showed that daptomycin degradation products do not possess bactericidal activity. The bioassay 
was compared to HPLC method that was previously developed and no significant difference was found 
between them (p>0.05). The method proved to be appropriate for daptomycin injection quality control.
Uniterms: Daptomycin/determination. Daptomycin injection/quality control. Turbidimetric 
microbiological assay/quantitative analysis.
A daptomicina (DPT) é o primeiro lipopeptídeo cíclico disponível para comercialização. Possui atividade 
frente a bactérias gram-positivas, incluindo cepas resistentes. O objetivo deste trabalho foi desenvolver 
e validar um ensaio microbiológico turbidimétrico para quantificar a daptomicina na forma injetável. 
Empregou-se delineamento 3x3, nas concentrações de 1,0; 2,0 e 4,0 µg/mL. Como micro-organismo teste 
foi usado Staphylococcus aureus ATCC 6538p, e Meio para Antibióticos nº 3 foi empregado como meio 
de cultura. A validação do método demonstrou que o ensaio foi linear (r=0,9995), preciso (RSD=2,55%), 
exato (recuperação de 100,48 ± 2,11%) e robusto. A cinética de degradação em meio alcalino foi 
avaliada, indicando que a daptomicina segue cinética de primeira ordem nessa condição. A análise das 
soluções degradadas mostrou que os produtos de degradação da daptomicina não possuem atividade 
antimicrobiana. O bioensaio foi comparado com o método por CLAE previamente desenvolvido e não 
houve diferença significativa entre ambos (p<0,05). O método mostrou-se apropriado para o controle 
de qualidade da daptomicina injetável. 
Unitermos: Daptomicina/determinação. Daptomicina injetável/controle de qualidade. Ensaio 
microbiológico turbidimétrico/análise quantitativa.
INTRODUCTION
When the first antibiotics, such as penicillin, 
began to be used in clinical medicine, around 1940, they 
were considered miracle drugs because they were able 
to treat serious infectious diseases, such as pneumonia 
and tuberculosis (Eom, Kim, Kim, 2013; Fernandes, 
2006). However, the widespread use of antimicrobials 
created constant selective pressure that resulted in the 
survival and spread of resistant bacteria. Microorganism 
resistance to antimicrobial agents has been reported 
for several pathogens, such as Staphylococcus aureus, 
Klebsiella pneumoneae, Streptococcus pneumoneae, 
Mycobacterium tuberculosis and Enterobacter species, 
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among others (Boucher et al., 2013; Spellberg et al., 
2008). 
New antibiotics have been approved over the last 
decade, such as: linezolid (US in 2000/EU in 2001), 
tigecycline (US in 2005/EU in 2006), DPT (US in 2003/
EU in 2006) and telavancin (US in 2009) (Boucher et al., 
2013; Sakoulas, 2009). 
The focus of this study is DPT (Figure 1), which is 
a cyclic lipopeptide with activity limited to gram-positive 
bacteria, such as Staphylococcus aureus, Enterococcus 
faecalis, and Streptococcus pneumoneae, including 
multidrug-resistant and susceptible strains (Koeth, 
Thorne, 2010; Lu et al., 2011; Steenbergen et al., 2005). 
The molecule is obtained from a strain of Streptomyces 
roseosporus and was originally known as LY 146032 
(Debono et al., 1987; Eliopoulos et al., 1986). The action 
mechanism is physiologic calcium dependent and possibly 
involves the disruption of amino acid transport by the cell 
membrane and changes in the cytoplasmic membrane 
potential (Debono et al., 1987; Koeth, Thorne, 2010; Lu 
et al., 2011). 
Some LC methods have been reported in the 
literature in order to determine DPT in some biological 
fluids, such as serum (Deryke et al., 2006; Rybak et 
al., 1992; Tobin et al., 2008), blood (Gikas et al., 2009; 
Olszowy et al., 2010), and plasma (Baietto et al., 2010; 
Dvorchik et al., 2003; Martens-Lobenhofer et al., 2008; 
Verdier et al., 2011). Recently, an HPLC method focusing 
on the assay of daptomycin injection was reported, which 
is the only pharmaceutical form available (Christ et al., 
2014). However, no methods to determine daptomycin 
in pharmaceutical form have been reported in the 
pharmacopoeias. 
Because of increasing pathogen resistance and 
the difficulty in developing new antimicrobial drugs, 
it is relevant to ensure the quality of those available on 
the market. Two methods are commonly used to assay 
antibiotics in pharmaceuticals: agar diffusion and broth 
turbidity (turbidimetric assay). Both enable estimating 
antibiotic potency through a direct comparison of a test 
antibiotic with a reference substance. Using these assays, 
it is possible to perceive reduction in antimicrobial activity 
caused by subtle changes that are not demonstrable by 
chemical methods. Therefore, microbial or biological 
assays generally remain the standard for solving any doubt 
concerning a possible loss of activity (USP, 2007). 
The aim of this study was to develop and validate 
a simple, specific, accurate, reproducible, and stability-
indicative turbidimetric microbiological assay to quantify 
injectable daptomycin. Moreover, a high performance 
liquid chromatographic (HPLC) method, developed and 
validated in our laboratory was chosen as a comparison 
method to determine daptomycin in degraded samples. 
EXPERIMENTAL
Chemical and reagents
The DPT reference substance was supplied by Hisun 
Pharmaceutical Hangzhou, Co., Ltd. (Xukow Town, 
China) and was used as purchased. Cubicin® (Novartis, São 
Paulo, Brazil) containing 500 mg of DPT in powder form 
for injection or infusion (excipient: sodium hydroxide) 
was kindly provided by Hospital Universitário de Santa 
Maria (HUSM) within their shelf life. Antibiotic Medium 
1 and Antibiotic Medium 2 were obtained from Himedia 
(Brazil) and Antibiotic Medium 3 was obtained from 
Difco (Brazil). All the chemicals were of pharmaceutical 
or special analytic grade. For all the analyses, ultrapure 
water was purified using a Millipore MilliQ® A 10 water 
system (Billerica, MA, USA). 
Preparation of reference substance and sample 
solutions
Both of the stock solutions (reference substance 
and sample) were prepared by dissolving the equivalent 
of 10 mg of DPT and diluting with ultrapure water in 
order to obtain 100 µg mL-1 solutions. To conduct the 
microbiological assay, the stock solutions of reference 
substance and sample were prepared on the day of the 
assay and diluted with the same solvent to concentrations 
of 1, 2, and 4 µg mL-1.
Preparation of a calcium stock solution
 A stock solution of calcium was prepared diluting 
3.67 g of calcium chloride dihydrate in a volumetric flask 
of 100 mL with ultrapure water, obtaining a concentration 
FIGURE 1 - Chemical structure of daptomycin.
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of 36.7 mg mL-1 (equivalent to 10 mg mL-1 of calcium). 
This solution was sterilized, stored at 2-8 °C, and added 
to the culture medium after the sterilization process. 
Microorganism and inoculum standardization
The microorganism that was used in this assay was 
Staphylococcus aureus ATCC 6538p. The microorganism 
was stored at 2-8 °C in Antibiotic Medium No. 1 agar. 
Twenty-four hours before the assay it was inoculated 
into another test tube with the same agar and incubated 
at 35 ± 2 °C. The bacteria was suspended and diluted in 
saline in order to obtain a suitable suspension with 25% ± 
2 of transmittance in 580 nm, using a spectrophotometer 
(Shimadzu UV-1800). Saline was used as blank. This 
microorganism suspension (named inoculum) was stored 
at 2-8 °C for 7 days and was added to the fluid medium, 
as described in the next section. 
Turbidimetric method 
A 3x3 design was chosen for the development of 
the microbiological method. In this model, three standard 
and sample solutions in the same presumed concentration 
are compared in order to determine the antibiotic (FB 
5, 2010). At first, 1 mL of inoculum was added to 100 
mL of sterilized Antiobiotic Medium 3. Then, 9 mL of 
inoculated medium and 1 mL of a sample or standard 
solution (at the concentration of 1, 2 and 4 µg mL-1) were 
added to the test tube. After that, they were incubated 
at 37 °C for 5 hours in a water bath with circulation. 
Concomitantly, negative test tubes (9 mL of Antibiotic 
Medium 3 and 1 mL of water) and positive test tubes 
(9 mL of inoculated Antibiotic Medium 3 and 1 mL of 
water) were incubated. All the test tubes were prepared 
in triplicate. The test tubes were randomly distributed in 
the water bath and the same time interval for loading and 
unloading each one was observed.
A f t e r  i n c u b a t i o n ,  t h e  m u l t i p l i c a t i o n  o f 
microorganisms was stopped by the addition of 0.5 mL 
of 12% formaldehyde solution in each one of test tubes, 
including positive and negative controls. The absorbance 
of the samples, reference substance, and control test tubes 
was determined at 530 nm, using the negative control as 
blank. The HEWITT equation was used to calculate de 
potency of DPT samples (Hewitt, 2003). 
Method validation
The method was validated according to the 
International Conference on Harmonization (ICH, 2005) 
by determining the following parameters: specificity, 
linearity, precision, accuracy, and robustness. 
Specificity
The capacity of the method to determine DPT in 
the presence of degradation products was evaluated by 
comparing the results obtained from the same sample 
degraded and analyzed by the HPLC method (previously 
validated by our research group) and microbiologic 
assay. To promote the drug degradation, 5 mL of DPT 
100 µg mL-1 were mixed with 5 mL of sodium hydroxide 
0.01mol/L; after 30 minutes, the solution was neutralized 
with hydrochloric acid 0.1 mol/L. After neutralization, 1 
mL of the samples was mixed with 9 mL of inoculated 
Antibiotic Medium 3 and incubated at 37 °C for 5 hours 
in a water bath with circulation. After incubation, the 
absorbance of the samples, reference substance, and 
control test tubes was determined at 530 nm. The analyses 
were accessed in duplicate.
Linearity
Three doses of reference substance solutions were 
used (1, 2, and 4 µg mL-1) in six independent assays. 
Results were subjected to regression analysis by the least-
squares method. The graph was obtained using the software 
Microsoft Excel (2010), by plotting the logarithm of the 
concentration versus the average of the absorbance values 
of each solution of DPT reference substance. ANOVA was 
used to confirm the validity of the assay, and parameters of 
linearity, parallelism and regression were evaluated.
Precision
The precision was determined by repeatability and 
intermediate precision and the results were expressed 
as relative standard deviation (RSD). Repeatability was 
evaluated by assaying two independent DPT samples on 
the same day and under the same experimental conditions 
(intraday); intermediate precision was evaluated by 
assaying two independent samples per day, on six 
different days (inter-day). Sample solutions were prepared 
according to section “Preparation of reference substance 
and sample solutions”. 
Accuracy
Accuracy was determined by recovering known 
quantities of the reference substance that was added to 
the samples. Recovery was determined at three levels 
named R1, R2 and R3 (70, 100 and 130% of work 
concentration). Sample solutions of DPT and reference 
substance solutions were prepared according to section 
“Preparation of reference substance and sample solutions”. 
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Aliquots of 1 mL of the sample solution (100 µg mL-1) and 
aliquots of 0.4, 1.0 and 1.6 mL of the reference substance 
solution (100 µg mL-1) were mixed and diluted with 
ultrapure water at 100 mL obtaining a final concentration 
of 1.4, 2.0 and 2.6 µg mL-1 (named R1, R2 and R3 
respectively). One milliliter of these final solutions was 
added to test tubes containing 9 mL culture medium. 
The tubes were incubated at 37 °C for 5 hours in a water 
bath with circulation. After incubation, the absorbance of 
samples, reference substance, and control test tubes was 
determined at 530 nm. The percentage recovery of DPT 
was calculated.
Robustness
The robustness was evaluated by analyzing the 
effect on the assay values promoted by variations in 
two experimental factors: incubation time and calcium 
concentration. As incubation time values of 4.5, 5.0 and 
5.5 h were used; the effect of calcium concentration was 
evaluated at 45, 50 and 55 µg mL-1. Both were evaluated 
in the range of ± 10% around the optimized value. The 
assays were performed in duplicate. 
Degradation kinetics in alkaline medium
DPT sample solution at 100 ug mL-1 was stored with 
0.01 mol/L sodium hydroxide during 0, 30, 60, 90 and 120 
minutes. At the end of each exposure time, solutions were 
neutralized with hydrochloric acid and the concentration 
was adjusted to 2.5 µg mL-1 with water in order to perform 
a turbidimetric assay and to 25 µg mL-1 for an HPLC assay. 
The assay was performed in duplicate.
The degradation kinetics of solutions was determined 
by plotting concentration versus time, ln of concentration 
versus time and the reciprocal of concentration versus 
time (zero-order, first-order and second-order process, 
respectively). The reaction order was indicated by the 
best fit to model, indicated by the regression coefficient 
(r). Parameters such as the degradation rate constant (k), 
half-life (t1/2, time to decrease the drug content to 50%) 
and t90 (time for 10% decomposition) were calculated by 
equations inherent to the reaction order. 
HPLC method
The chromatographic method, previously reported 
(Christ et al., 2014), was developed in a Shimadzu® 
liquid chromatograph with a Waters XBridge C18 
column (250 mm x 4.6 mm, 5 µm). The mobile phase 
was acetonitrile, methanol and phosphate buffer pH 2.2 
(30:40:30 v/v), at a flow rate of 1 mL min -1 and isocratic 
elution. The run time was 10 min and the injection volume 
was 20 µL. DPT was determined by UV detection at 
223 nm using a photodiode-array detector.
Comparison of the methods
In order to compare the results obtained by the 
chromatographic method and microbiologic assay, the 
precision results of both methods were statistically 
analyzed using two-one-sided-test (TOST) (XLSTAT 
Version 2015.4.01 for Windows). 
RESULTS AND DISCUSSION
Preliminary studies
The potency of antibiotics in pharmaceuticals can 
be assessed by a cylinder-plate assay (also known as agar 
diffusion assay) and the turbidimetric assay. Agar diffusion 
is usually the method of choice when the characteristics of 
an antibiotic allow for using it (particularly water-soluble 
compounds). Turbidimetric assay is used less widely 
than the diffusion assay, although it might be considered 
to resemble the clinical situation more closely. It is more 
commonly used to assay antibiotics that are poorly soluble 
in water (Baird, Hodges, Denyer, 2000).
Our first attempts were aimed at developing an 
agar diffusion method, considering its widespread usage 
and the aqueous solubility of DPT. We used the 3x3 
design, in a bilayer system with six plates for each assay. 
Staphylococcus aureus ATCC 6538p was selected and the 
culture media were the most used for this microorganism 
(USP, 2007; ANVISA, 2010) (Antibiotic Medium 1 and 
Antibiotic Medium 2). DPT solutions in a wide range 
were tested (1.5 to 80 µg mL-1) and, according to the 
results, DPT concentrations of 8, 16, and 32 µg mL-1 were 
chosen. The plates were prepared and, after incubation 
(37ºC/18 hours), the inhibition zones formed by the 
reference substance and sample solutions were compared 
(ANVISA, 2010).
The mean inhibition zones obtained for the DPT 
reference substance were 12.11 mm ± 3.23, 14.44 mm 
± 1.79, and 16.26 mm ± 2.12, for 8, 16 and 32 µg mL-1, 
respectively. These results show the method’s inability 
to detect differences in drug content, since only small 
changes were observed in the inhibition zones, in spite of 
the wide concentration range used. Similar responses are 
reported for other drugs with a high molecular weight, 
such as vancomycin, teicoplanin, and polymyxins and 
are attributed to their difficulty in diffusing in solid media 
(Koeth, Thorne, 2010). Considering these results, we gave 
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up on the agar diffusion assay and started to develop the 
turbidimetric assay.
Calcium concentration
The effect of calcium on the action mechanism of 
DPT was initially reported in 1986 (Eliopoulos et al., 
1986). A subsequent study demonstrated that DPT MICs 
are generally twofold to fourfold lower when tested in 
broth containing 50 µg mL-1 of calcium (Fuchs, Barry, 
Brown, 2000). Another more recent study also confirms 
the results obtained in previous studies, suggesting the 
important presence of calcium in susceptible assays 
using culture medium containing or supplemented with 
50 µg mL-1 of calcium (Koeth, Thorne, 2010).
Tests with and without calcium were performed by 
the two methods studied in order to verify the need for 
calcium in the microbiological assay. In both methods, 
calcium was added to the culture media after sterilization. 
The means of the diameter zones without calcium were 
8.37, 9.36, and 10.23 mm, respectively and 13.05, 14.99, 
and 16.33 with calcium (agar diffusion assay). The 
absorbances that were found in the assay with calcium 
were 0.275, 0.167, and 0.067, and without calcium they 
were 0.271, 0.287, and 0.289. These results demonstrated 
that in the absence of calcium there was visibly less 
antimicrobial activity than when calcium was used at 
50 µg mL-1. 
Turbidimetric assay
Several assays under different conditions were 
conducted to establish the optimal conditions to develop 
the turbidimetric method (Table I). The best results 
were found under the following conditions: Antibiotic 
Medium 3 (fluid), supplemented with calcium; inoculum 
concentration at 1.0% (Staphylococcus aureus ATCC 
6538p); 5 hours of incubation (37ºC) and reference 
substance and sample solutions at 1.0, 2.0, and 4.0 µg 
mL-1, diluted in water. Staphylococcus aureus was used 
considering the microbial activity of DPT. Time and 
temperature of incubation are in agreement with the 
recommended values for this microorganism. Absorbance 
values in the range of 0.1 to 0.5 are considered indicative 
of the suitability of the conditions employed (Baird, 
Hodges, Denyer, 2000); thus, they were used to define 
the inoculum concentration. Water was used to dilute the 
sample considering the high DPT aqueous solubility. 
Specificity
According to the literature (Alsante et al., 2007), 
degradation in the range of 5-20% is sufficient to show 
that there is no interference of degradation products in 
the tests performed under acidic or basic conditions. 
Preliminary tests indicated a high degradation rate in 
the alkaline medium. Thus, we employed 0.01 mol/L 
NaOH, at room temperature. Samples were assayed 
by the bioassay and HPLC methods, respectively, and 
similar results were found, 86.9% (n= 2, RSD 3.16 %) 
and 82.4% (n=3, RSD 1.78 %). These results confirmed 
the stability characteristic of the assay, since it showed 
the sample potency against a microorganism, in the 
presence of degradation products.
Linearity
The calculation procedure usually assumes a direct 
relationship between the absorbance and logarithm of the 
respective dose. The corresponding mean absorbances 
for the reference substance solutions were: 0.3035 for the 
lower dose (1 µg mL-1), 0.1995 for the intermediate dose 
(2 µg mL-1), and 0.1058 for the higher dose (4 µg mL-1). 
The dose-response lines for DPT solutions (sample and 
reference substance) were constructed by plotting log 
concentrations (µg mL-1) versus absorbance and showed 
good linearity between the range of 1 and 4 µg mL-1. 
The representative linear equation for DPT reference 
substance was y = -0.3284log(x) + 0.3018, r = 0.9995 for 
DPT sample. According to ANOVA, the assay showed 
significant regression (p<0.05) and no deviation from 
linearity and from parallelism (p>0.05), meeting the 
requirements of 3x3 design (FB 5, 2010). 
TABLE I - Conditions tested to establish the turbidimetric assay conditions
Parameters Conditions
Standard curve points (µg/mL) 0.1, 0.25 and 0.5; 0.5, 1.0 and 2.0; 1.0, 2.0 and 4.0
Culture medium Casoy Broth; Antibiotic Medium 3
Inoculum concentration (%) 0.2; 0.4; 0.5; 0.8 and 1.0
Incubation time (hours) 3.0; 4.0 and 5.0
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Precision
The precision of the assay was evaluated at two 
levels: repeatability (intra-day, n=2/day) and intermediate 
precision (inter-day, 6 days) and the results are expressed 
as the RSD of the measurement series (Table II). The 
potency of the sample was calculated by the Hewitt 
equation, which compares the dose-response lines from 
the sample and reference substance. Low RSD values 
were obtained, confirming the precision of this method. 
Accuracy
The accuracy of the bioassay proposed was accessed 
by the standard addition method. The results obtained 
showed good recovery of the drug added to the sample 
solutions (Table III). The mean recovery value was 
100.48% and RSD 2.11%, which confirms the suitability 
of the analytical conditions employed and ensures the 
ability of the method to quantify DPT concentrations 
within the range of 70 to 130% of the target value. 
Robustness
The results of the robustness evaluation are 
shown in Table IV. The results obtained indicate that the 
modifications in the method parameters did not cause 
significant differences in the DPT assay (p>0.05). 
Kinetic degradation
A linear relationship between the ln of the remaining 
concentrations versus time was observed. This indicated 
that the reaction of DPT degradation under the condition 
evaluated followed first-order kinetics and that the 
degradation rate depends on the reagent concentration 
(Lachman, Lieberman, Kanig, 2001). The rate constant 
order (k) was determined by the graphic equation 
and the values obtained were 0.0055 µg mL min-1 and 
0.0047 µg mL min-1 by bioassay and HPLC methods, 
respectively. 
Through the data obtained it was also possible to 
determine the half-life and t90 of daptomycin under the 
TABLE II - Values obtained in the determination of daptomycin (DPT) injection by turbidimetric assay
Sample
Potency (% of label claim)
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6
1 100.88 98.15 97.22 102.64 104.31 102.02
2 100.22 99.18 97.72 104.38 104.11 100.65
Mean intra-day 100.55 98.67 97.47 103.51 104.21 101.34
RSD Intra-day 0.46 0.74 0.36 1.19 0.14 0.96
Mean inter-day 100.96
RSD inter-day 2.58
TABLE III - Accuracy of the turbidimetric assay
Sample Reference substance 
added (µg/mL)
Concentration 
recovered (µg/mL)
Recovery (%) Mean (%) RSD (%)
R1 0.4 0.3849 96.23
0.3942 100.75 98.51 2.29
0.4025 98.55
R2 1.0 1.0085 100.85
1.0152 101.84 101.40 0.50
1.0184 101.52
R3 1.6 1.5927 99.54
1.6517 101.82 102.29 0.80
1.6294 103.23
Mean recovery(%) 100.48
RSD 2.09
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TABLE IV - Robustness determination of the DPT turbidimetric assay
Daptomycin assay (% of theoretical value)
Optimized 
condition*
Calcium concentration (µg mL-1) Incubation time (h)
55 45 4.5 5.5
Assay 1 99.11 99.37 100.55 99.94 99.79
Assay 2 100.44 99.89 101.13 100.40 99.19
* calcium concentration at 50 µg.mL-1, incubation time 5 hours.
degradation condition employed. The obtained values 
were 128.37 and 19.36 minutes (t1/2 and t90, turbidimetric 
bioassay) and 130.81 and 22.55 minutes (t1/2 and t90, HPLC 
assay). These data are in agreement with the experimental 
values (degradation of 43.5% in 120 minutes, turbidimetric 
bioassay). The results of the two methods indicated that 
both produce a similar percentage remaining of DPT 
(Figure 2). 
 Furthermore, the analyses of degraded solutions 
confirmed the sensitivity of the biological assay to 
quantify DPT in degraded samples and showed that DPT 
degradation products do not present bactericidal activity. 
This is important information for the health-system 
pharmacists, in the sense of avoiding dilution with alkaline 
diluents, such as sodium bicarbonate. 
Conversely, residual samples of DPT must be 
discarded 24 h after reconstitution, according to the 
manufacturer’s recommendation. Thus, the obtained 
results suggest that DPT solutions can be treated with 
alkaline solutions before being discarded, contributing to 
the reduction of environmental damage. 
Comparison of methods
The results obtained in the turbidimetric bioassay 
FIGURE 2 - DPT assay after alkaline degradation at 0, 30, 60, 
90 and 120 minutes of exposure, by the turbidimetric bioassay 
and HPLC methods.
were compared to those obtained by the HPLC method, 
previously validated by our group (Christ et al., 2014). 
By microbiological assay, the mean potency (potency 
± RSD%, n = 12) was 100.96 ± 2.58 and by the HPLC 
method it was 100.23 ± 0.59 (assay ± RSD%, n=12). 
These results were statistically evaluated by the two-one-
sided-test (TOST), considering a significance level of 5% 
and confidence interval of 90%. The null hypothesis can 
be accepted and consequently, the analytical methods 
considered equivalent when the confidence interval for 
the difference is completely contained within the defined 
range considered to be scientifically trivial (± ∆). We 
defined ∆=5 as an appropriate range for the equivalence 
testing, based on the specifications of the precision 
test (RSD = 5%, ANVISA, 2003), and on the inherent 
variation of biological assays. TOST was applied and 
indicated equivalence between the two methods, as shown 
in Table V. 
The quantification of antibiotics by chemical 
methods, such as HPLC, presents some advantages such 
as shorter analysis time, possibility of automation, lower 
RSD values, and shorter time to review the robustness. 
Disadvantages can be the high cost of equipment and 
the large amounts of organic solvents used. Besides, the 
method cannot truly show biologic activity.
Biological methods have some advantages 
in  compar ison  to  methods  l ike  HPLC and UV 
spectrophotometry, such as the low cost of the equipment 
TABLE V - TOST results for the comparison of the microbiological 
and HPLC methods
Test Value
Lower bound (TOST) -5,000
Lower bound (90%) -0,582
Upper bound (90%) 2,038
Upper bound (TOST) 5,000
Test interpretation Equivalent
α = 0.05
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(Manfio et al., 2013), the good relationship with clinical 
use, and they can determine the content and the biological 
activity. In spite of the high variability expected from 
the bioassays, in our study the RSD values obtained in 
precision evaluation are within the recommended limits. 
Therefore, this assay could be very useful to determine 
DPT in pharmaceutical dosage forms.
CONCLUSION
The proposed turbidimetric bioassay proved to 
be able to quantify the DPT injection. Although an agar 
diffusion assay is more used to quantify antimicrobials, 
the turbidimetric assay is faster and the measure of 
the response is automated. The method was validated 
according to ICH guidelines and demonstrated good 
linearity, precision, accuracy, robustness, specificity, and 
stability-indication. Therefore, it is an acceptable method 
for the routine quality control of daptomycin and useful 
in stability studies. 
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